Association between the ratio of serum creatinine to cystatin C and bone mineral density in Chinese older adults patients with type 2 diabetes mellitus

Association between the ratio of serum creatinine to cystatin C and bone mineral density in Chinese older adults patients with type 2 diabetes mellitus

BackgroundThe ratio of creatinine to cystatin C (Cre/CysC), a marker of muscle function and muscle mass, can be used to predict sarcopenia in different populations. Since sarcopenia is closely associated with osteoporosis, this study investigated the association between Cre/CysC and bone mineral den...

Full description

Bibliographic Details
Main Authors:	Ting Gao, Fupeng Liu, Bo Ban, Yue Hou, Guangxin Li, Mingming Jiang, Qing Yang, Mei Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Nutrition
Subjects:	type 2 diabetes creatinine cystatin C Cre/CysC bone mineral density
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2022.1035853/full

Similar Items

Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
by: Ping’an Ding, et al.
Published: (2022-09-01)

Association Between Serum Cystatin C and Thyroid Diseases: A Systematic Review and Meta-Analysis
by: Caihong Xin, et al.
Published: (2021-11-01)

Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
by: Jing Sun, et al.
Published: (2022-01-01)

Establishment of muscle mass-based indications for the cystatin C test in renal function evaluation
by: Jisook Yim, et al.
Published: (2022-11-01)

Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
by: Shanshan Shi, et al.
Published: (2022-08-01)

Serum creatinine to cystatin C ratio and cognitive function among middle-aged and older adults in China
by: Yueli Zhu, et al.
Published: (2022-09-01)

Non-linear association of cystatin C and all-cause mortality of heart failure: A secondary analysis based on a published database
by: Tao Zheng, et al.
Published: (2022-09-01)

Serum cystatin C levels in preterm newborns in our setting: Correlation with serum creatinine and preterm pathologies
by: Leonor Bardallo Cruzado, et al.
Published: (2015-05-01)

Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation
by: Hamid Eshraghi, et al.
Published: (2009-06-01)

Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study
by: Chan‐Young Jung, et al.
Published: (2022-08-01)

Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer
by: Mariko Tsukagoshi, et al.
Published: (2023-09-01)

Cystatin C versus Creatinine as Early Stage Diabetic Nephropathy Marker
by: Atteaya Zaman , Amena Rahim , Muhammad Afzal , Abdul Khaliq Naveed
Published: (2018-06-01)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
by: Hao Liu, et al.
Published: (2023-10-01)

A New Index Based on Serum Creatinine and Cystatin C Can Predict the Risks of Sarcopenia, Falls and Fractures in Old Patients with Low Bone Mineral Density
by: Jiaying Ge, et al.
Published: (2022-11-01)

Independent associations of urinary albumin-to-creatinine ratio and serum cystatin C with carotid intima-media thickness in community-living Taiwanese adults
by: Chiu-Shong Liu, et al.
Published: (2020-10-01)

Cystatin C Predicts Renal Recovery Earlier Than Creatinine Among Patients With Acute Kidney Injury
by: Kamel A. Gharaibeh, et al.
Published: (2018-03-01)

Sarcopenia Index Based on Serum Creatinine and Cystatin C is Associated with Mortality, Nutritional Risk/Malnutrition and Sarcopenia in Older Patients
by: Ren C, et al.
Published: (2022-03-01)

The coexistence of myosteatosis and the creatinine/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery
by: Yan Liu, et al.
Published: (2024-04-01)

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
by: Jung Nam An, et al.
Published: (2022-09-01)

A baseline sarcopenia index based on creatinine/cystatin C for the prediction of stroke recurrence and mortality in older survivors of first ischemic strokes
by: Lisha Hou, et al.
Published: (2023-09-01)

Clinical significance of serum cystatin C‐to‐creatinine ratio as a surrogate marker for incident osteoporotic fracture predictions
by: Ichiro Yoshii, et al.
Published: (2023-05-01)

Prognostic value of creatinine-to-cystatin c ratio in patients with type 2 diabetes mellitus: a cohort study
by: Wen Wei, et al.
Published: (2022-11-01)

Deviations from the expected relationship between serum FGF23 and other markers in children with CKD: a cross-sectional study
by: Daisy Liu, et al.
Published: (2017-06-01)

Estimation of glomerular filtration rate from serum cystatin C and creatinine in patients with thyroid dysfunction
by: Čabarkapa Velibor, et al.
Published: (2012-01-01)

Normalized Creatinine-to-Cystatin C Ratio and Risk of Diabetes in Middle-Aged and Older Adults: The China Health and Retirement Longitudinal Study
by: Shanhu Qiu, et al.
Published: (2022-05-01)

The outcome of acute kidney injury substages based on urinary cystatin C in critically ill children
by: Jiao Chen, et al.
Published: (2023-03-01)

Diagnostic Value of Serum Creatinine and Cystatin-C-Based Indices and Ishii Score in Cancer-Related Sarcopenia
by: Liming Ding, et al.
Published: (2023-06-01)

Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis
by: Wen-He Zheng, et al.
Published: (2023-01-01)

A Novel Application of Serum Creatinine and Cystatin C to Predict Sarcopenia in Advanced CKD
by: Yu-Li Lin, et al.
Published: (2022-02-01)

Estimating eGFR using Serum Cystatin C alone and in combination with Serum Creatinine: A Prospective study in individuals with CKD in north Telangana
by: B Venugopal1 , S Sangeeta2
Published: (2018-08-01)

Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients
by: Sichao Chen, et al.
Published: (2021-03-01)

Predictive value of serum creatinine/cystatin C in neurocritically ill patients
by: Shengnan Wang, et al.
Published: (2019-12-01)

Kidney injury molecule-1 and cystatin C as early biomarkers for renal dysfunction in Iraqi type 2 diabetes mellitus patients
by: Ansam Abdulameer Yahya, et al.
Published: (2023-12-01)

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
by: Shunhui Gao, et al.
Published: (2023-06-01)

The Inter-Trimester Variation and Prognostic Value of Creatinine, Cystatin C and Uric Acid in Preeclamptic Patients: A Retrospective Study
by: Junpeng Jing, et al.
Published: (2023-02-01)

Diagnostic Value of Cystatin C and Creatinine Detection in Blood Serum of Newborns at Ischemic Nephropathy
by: A.M. Loboda, et al.
Published: (2012-02-01)

Glomerular filtration rate determination by creatinine and cystatin-C in patients with acute pyelonephritis
by: Hadi Sorkhi, et al.
Published: (2018-05-01)

Differential Bias for Creatinine- and Cystatin C- Derived Estimated Glomerular Filtration Rate in Critical COVID-19
by: Anders O. Larsson, et al.
Published: (2022-10-01)

Sarcopenia index based on serum creatinine and cystatin C predicts the risk of postoperative complications following hip fracture surgery in older adults
by: Xiaoyan Chen, et al.
Published: (2021-10-01)

Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report
by: Natsumi Matsuoka, et al.
Published: (2020-03-01)